Feb 16 (Reuters) - Talaris Therapeutics Inc TALS.O :
* TALARIS THERAPEUTICS ANNOUNCES PLANS TO EXPLORE STRATEGIC
ALTERNATIVES AND IMPLEMENTS RESTRUCTURING PLAN
* TALARIS THERAPEUTICS INC - TO DISCONTINUE ITS FREEDOM-1
AND
FREEDOM-2 CLINICAL TRIALS
* TALARIS THERAPEUTICS INC - WILL CONTINUE TO ENROLL ITS
FREEDOM-3
PHASE 2 CLINICAL TRIAL
* TALARIS THERAPEUTICS INC- RESTRUCTURING PLAN INCLUDES
REDUCING
ITS WORKFORCE BY APPROXIMATELY ONE-THIRD
* TALARIS THERAPEUTICS INC - WILL SUSPEND FURTHER GUIDANCE
ON
STATUS OF ITS PROGRAMS
Source text for Eikon: ID:nGNXdy6lp
Further company coverage: TALS.O
((Reuters.Briefs@thomsonreuters.com;;))